Singapore Institute of Advanced Medicine Holdings Ltd. (SGX:9G2)
Singapore
· Delayed Price · Currency is SGD 0.0460
0.00 (0.00%)
At close: Apr 28, 2026
SGXC:9G2 Revenue
Singapore Institute of Advanced Medicine Holdings had revenue of 8.26M SGD in the half year ending December 31, 2025, a decrease of -3.35%. This brings the company's revenue in the last twelve months to 15.93M, down -1.27% year-over-year. In the fiscal year ending June 30, 2025, Singapore Institute of Advanced Medicine Holdings had annual revenue of 15.71M, down -5.63%.
Revenue (ttm)
15.93M
Revenue Growth
-1.27%
P/S Ratio
3.56
Revenue / Employee
n/a
Employees
n/a
Market Cap
56.65M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 15.71M | -936.78K | -5.63% |
| Jun 30, 2024 | 16.65M | 412.41K | 2.54% |
| Jun 30, 2023 | 16.23M | 2.43M | 17.56% |
| Jun 30, 2022 | 13.81M | 891.35K | 6.90% |
| Jun 30, 2021 | 12.92M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Megachem | 124.41M |
| Lincotrade & Associates Holdings | 93.26M |
| Attika Group | 37.55M |
| HC Surgical Specialists | 19.14M |
| Audience Analytics | 15.96M |
| Kim Heng | 120.99M |
| Atlantic Navigation Holdings (Singapore) | 26.24M |
| YKGI Limited | 70.16M |